<DOC>
	<DOCNO>NCT00006112</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Randomized phase II trial compare effectiveness fluorouracil without mitomycin treat patient peritoneal cancer .</brief_summary>
	<brief_title>Fluorouracil With Without Mitomycin Treating Patients With Peritoneal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare efficacy adjuvant systemic fluorouracil intraperitoneal mitomycin v systemic fluorouracil alone term survival patient peritoneal cancer originate colorectum . OUTLINE : This randomize , multicenter study . Patients stratify accord center mode surgery . Patients randomize one two treatment arm . Arm I : Patients undergo complete resection tumor day 0 . Patients receive mitomycin intraperitoneally ( IP ) 23 hour day 1 fluorouracil IP 24 hour day 2-5 . Patients receive one three systemic chemotherapy regimens 6 month : Regimen I : Patients receive leucovorin calcium IV 2 hour fluorouracil IV 22 hour day 1 2 . Treatment repeat every 2 week . Regimen II : Patients receive fluorouracil IV continuously 7 week . Treatment repeat every 8 week . Regimen III : Leucovorin calcium fluorouracil administer per standard procedure . Arm II : Patients receive treatment arm I without early intraperitoneal chemotherapy . Patients follow every 3 month 2 year . PROJECTED ACCRUAL : At least 90 patient ( 45 per arm ) accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Appendiceal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven peritoneal cancer amenable total resection Originated colorectal adenocarcinoma cancer appendix No diffuse ( unresectable ) tumors No microscopic cancer No hepatic , lymph node , extraabdominal metastasis preoperative workup No primitive peritoneal mesothelioma No peritoneal pseudomyxomas ascites No cancer originate ovarian neuroendocrine cancer , especially sarcomas ( intra retroperitoneal ) Complete resection tumor deposit No originate cancer unknown origin PATIENT CHARACTERISTICS : Age : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : WBC great 1,500/mm3 Platelet count great 100,000/mm3 No chronic hematologic disorder No coagulation disorder Hepatic : Not specify Renal : Creatinine le 1.36 mg/dL Other : No significant medical condition would preclude study PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2001</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>carcinoma appendix</keyword>
	<keyword>primary peritoneal cavity cancer</keyword>
</DOC>